The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Imipenem Astatin Sodium for Injection Market Research Report 2024

Global Imipenem Astatin Sodium for Injection Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1762960

No of Pages : 86

Ask Your Query

Synopsis
Imipenem and cilastatin are broad-spectrum antibiotics, suitable for mixed infections caused by various pathogens and aerobic/anaerobic bacteria, as well as early treatment before the pathogens are not identified.

Global Imipenem Astatin Sodium for Injection market is projected to reach US$ 3561 million in 2029, increasing from US$ 2400 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Imipenem Astatin Sodium for Injection market research.

Key manufacturers engaged in the Imipenem Astatin Sodium for Injection industry include MSD, Shandong New Era Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Merck Sharp & Dohme Corp., Taiwan Biotech Co., Ltd., Sun Pharmaceutical Industries Ltd., JW PHARMACEUTICAL CORPORATION and Gentle Pharma Co.,Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Imipenem Astatin Sodium for Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Imipenem Astatin Sodium for Injection market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Imipenem Astatin Sodium for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • MSD
  • Shandong New Era Pharmaceuticals
  • Shenzhen Haibin Pharmaceutical
  • Sinopharm Guorui Pharmaceutical
  • Merck Sharp & Dohme Corp.
  • Taiwan Biotech Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • JW PHARMACEUTICAL CORPORATION
  • Gentle Pharma Co.,Ltd.

Segment by Type

  • 0.5G
  • 1.0G

Segment by Application

  • Hospital
  • Clinic
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Imipenem Astatin Sodium for Injection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Imipenem Astatin Sodium for Injection Market Overview
1.1 Product Overview and Scope of Imipenem Astatin Sodium for Injection
1.2 Imipenem Astatin Sodium for Injection Segment by Type
1.2.1 Global Imipenem Astatin Sodium for Injection Market Value Comparison by Type (2023-2029)
1.2.2 0.5G
1.2.3 1.0G
1.3 Imipenem Astatin Sodium for Injection Segment by Application
1.3.1 Global Imipenem Astatin Sodium for Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Imipenem Astatin Sodium for Injection Market Size Estimates and Forecasts
1.4.1 Global Imipenem Astatin Sodium for Injection Revenue 2018-2029
1.4.2 Global Imipenem Astatin Sodium for Injection Sales 2018-2029
1.4.3 Global Imipenem Astatin Sodium for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Imipenem Astatin Sodium for Injection Market Competition by Manufacturers
2.1 Global Imipenem Astatin Sodium for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Imipenem Astatin Sodium for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Imipenem Astatin Sodium for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Imipenem Astatin Sodium for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Imipenem Astatin Sodium for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Imipenem Astatin Sodium for Injection, Product Type & Application
2.7 Imipenem Astatin Sodium for Injection Market Competitive Situation and Trends
2.7.1 Imipenem Astatin Sodium for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Imipenem Astatin Sodium for Injection Players Market Share by Revenue
2.7.3 Global Imipenem Astatin Sodium for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Imipenem Astatin Sodium for Injection Retrospective Market Scenario by Region
3.1 Global Imipenem Astatin Sodium for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Imipenem Astatin Sodium for Injection Global Imipenem Astatin Sodium for Injection Sales by Region: 2018-2029
3.2.1 Global Imipenem Astatin Sodium for Injection Sales by Region: 2018-2023
3.2.2 Global Imipenem Astatin Sodium for Injection Sales by Region: 2024-2029
3.3 Global Imipenem Astatin Sodium for Injection Global Imipenem Astatin Sodium for Injection Revenue by Region: 2018-2029
3.3.1 Global Imipenem Astatin Sodium for Injection Revenue by Region: 2018-2023
3.3.2 Global Imipenem Astatin Sodium for Injection Revenue by Region: 2024-2029
3.4 North America Imipenem Astatin Sodium for Injection Market Facts & Figures by Country
3.4.1 North America Imipenem Astatin Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Imipenem Astatin Sodium for Injection Sales by Country (2018-2029)
3.4.3 North America Imipenem Astatin Sodium for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Imipenem Astatin Sodium for Injection Market Facts & Figures by Country
3.5.1 Europe Imipenem Astatin Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Imipenem Astatin Sodium for Injection Sales by Country (2018-2029)
3.5.3 Europe Imipenem Astatin Sodium for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Imipenem Astatin Sodium for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Imipenem Astatin Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Imipenem Astatin Sodium for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Imipenem Astatin Sodium for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Imipenem Astatin Sodium for Injection Market Facts & Figures by Country
3.7.1 Latin America Imipenem Astatin Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Imipenem Astatin Sodium for Injection Sales by Country (2018-2029)
3.7.3 Latin America Imipenem Astatin Sodium for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Imipenem Astatin Sodium for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Imipenem Astatin Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Imipenem Astatin Sodium for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Imipenem Astatin Sodium for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Imipenem Astatin Sodium for Injection Sales by Type (2018-2029)
4.1.1 Global Imipenem Astatin Sodium for Injection Sales by Type (2018-2023)
4.1.2 Global Imipenem Astatin Sodium for Injection Sales by Type (2024-2029)
4.1.3 Global Imipenem Astatin Sodium for Injection Sales Market Share by Type (2018-2029)
4.2 Global Imipenem Astatin Sodium for Injection Revenue by Type (2018-2029)
4.2.1 Global Imipenem Astatin Sodium for Injection Revenue by Type (2018-2023)
4.2.2 Global Imipenem Astatin Sodium for Injection Revenue by Type (2024-2029)
4.2.3 Global Imipenem Astatin Sodium for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Imipenem Astatin Sodium for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Imipenem Astatin Sodium for Injection Sales by Application (2018-2029)
5.1.1 Global Imipenem Astatin Sodium for Injection Sales by Application (2018-2023)
5.1.2 Global Imipenem Astatin Sodium for Injection Sales by Application (2024-2029)
5.1.3 Global Imipenem Astatin Sodium for Injection Sales Market Share by Application (2018-2029)
5.2 Global Imipenem Astatin Sodium for Injection Revenue by Application (2018-2029)
5.2.1 Global Imipenem Astatin Sodium for Injection Revenue by Application (2018-2023)
5.2.2 Global Imipenem Astatin Sodium for Injection Revenue by Application (2024-2029)
5.2.3 Global Imipenem Astatin Sodium for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Imipenem Astatin Sodium for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 MSD
6.1.1 MSD Corporation Information
6.1.2 MSD Description and Business Overview
6.1.3 MSD Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 MSD Imipenem Astatin Sodium for Injection Product Portfolio
6.1.5 MSD Recent Developments/Updates
6.2 Shandong New Era Pharmaceuticals
6.2.1 Shandong New Era Pharmaceuticals Corporation Information
6.2.2 Shandong New Era Pharmaceuticals Description and Business Overview
6.2.3 Shandong New Era Pharmaceuticals Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Shandong New Era Pharmaceuticals Imipenem Astatin Sodium for Injection Product Portfolio
6.2.5 Shandong New Era Pharmaceuticals Recent Developments/Updates
6.3 Shenzhen Haibin Pharmaceutical
6.3.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.3.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.3.3 Shenzhen Haibin Pharmaceutical Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Shenzhen Haibin Pharmaceutical Imipenem Astatin Sodium for Injection Product Portfolio
6.3.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.4 Sinopharm Guorui Pharmaceutical
6.4.1 Sinopharm Guorui Pharmaceutical Corporation Information
6.4.2 Sinopharm Guorui Pharmaceutical Description and Business Overview
6.4.3 Sinopharm Guorui Pharmaceutical Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sinopharm Guorui Pharmaceutical Imipenem Astatin Sodium for Injection Product Portfolio
6.4.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
6.5 Merck Sharp & Dohme Corp.
6.5.1 Merck Sharp & Dohme Corp. Corporation Information
6.5.2 Merck Sharp & Dohme Corp. Description and Business Overview
6.5.3 Merck Sharp & Dohme Corp. Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck Sharp & Dohme Corp. Imipenem Astatin Sodium for Injection Product Portfolio
6.5.5 Merck Sharp & Dohme Corp. Recent Developments/Updates
6.6 Taiwan Biotech Co., Ltd.
6.6.1 Taiwan Biotech Co., Ltd. Corporation Information
6.6.2 Taiwan Biotech Co., Ltd. Description and Business Overview
6.6.3 Taiwan Biotech Co., Ltd. Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Taiwan Biotech Co., Ltd. Imipenem Astatin Sodium for Injection Product Portfolio
6.6.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates
6.7 Sun Pharmaceutical Industries Ltd.
6.6.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.6.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Ltd. Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sun Pharmaceutical Industries Ltd. Imipenem Astatin Sodium for Injection Product Portfolio
6.7.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.8 JW PHARMACEUTICAL CORPORATION
6.8.1 JW PHARMACEUTICAL CORPORATION Corporation Information
6.8.2 JW PHARMACEUTICAL CORPORATION Description and Business Overview
6.8.3 JW PHARMACEUTICAL CORPORATION Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 JW PHARMACEUTICAL CORPORATION Imipenem Astatin Sodium for Injection Product Portfolio
6.8.5 JW PHARMACEUTICAL CORPORATION Recent Developments/Updates
6.9 Gentle Pharma Co.,Ltd.
6.9.1 Gentle Pharma Co.,Ltd. Corporation Information
6.9.2 Gentle Pharma Co.,Ltd. Description and Business Overview
6.9.3 Gentle Pharma Co.,Ltd. Imipenem Astatin Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gentle Pharma Co.,Ltd. Imipenem Astatin Sodium for Injection Product Portfolio
6.9.5 Gentle Pharma Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Imipenem Astatin Sodium for Injection Industry Chain Analysis
7.2 Imipenem Astatin Sodium for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Imipenem Astatin Sodium for Injection Production Mode & Process
7.4 Imipenem Astatin Sodium for Injection Sales and Marketing
7.4.1 Imipenem Astatin Sodium for Injection Sales Channels
7.4.2 Imipenem Astatin Sodium for Injection Distributors
7.5 Imipenem Astatin Sodium for Injection Customers
8 Imipenem Astatin Sodium for Injection Market Dynamics
8.1 Imipenem Astatin Sodium for Injection Industry Trends
8.2 Imipenem Astatin Sodium for Injection Market Drivers
8.3 Imipenem Astatin Sodium for Injection Market Challenges
8.4 Imipenem Astatin Sodium for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock